Hiroshi Komazaki
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Perioperative Systemic Treatment Patterns and Postoperative Mortality Among Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy in Japan: WAKKA-MIBC Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: March 16, 2026
Long-term (68 weeks) administration of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: efficacy and safety data from a phase III study.
Journal: The British journal of dermatology
Published: July 30, 2024
Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged ≥ 13 years.
Journal: The British journal of dermatology
Published: December 17, 2023
Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: results from a phase III, randomized, double-blind, placebo-controlled, multicentre study.
Journal: The British journal of dermatology
Published: May 17, 2023
Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial.
Journal: Dermatology and therapy
Published: November 15, 2022
A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.
Journal: The Journal of dermatology
Published: August 15, 2022
Single-Dose, Patient-Initiated Amenamevir Therapy for Recurrent Genital Herpes: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
Journal: Open forum infectious diseases
Published: June 30, 2022
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long-term studies.
Journal: The British journal of dermatology
Published: October 29, 2021
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
Journal: The New England journal of medicine
Published: July 09, 2020
Ca2+ -dependent down-regulation of human histamine H1 receptors in Chinese hamster ovary cells.
Journal: Journal of neurochemistry
Published: February 20, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026